Evolent Health, Inc. Q4 2023 Earnings Call Transcript
EVH Stock | USD 12.92 0.01 0.08% |
Under 53% of Evolent Health's investor base is interested to short. The analysis of the overall investor sentiment regarding Evolent Health suggests that many traders are impartial. Evolent Health's investing sentiment shows overall attitude of investors towards Evolent Health.
Evolent |
Evolent Health, Inc. Q4 2023 Earnings Call Transcript February 22, 2024 Evolent Health, Inc. isnt one of the 30 most popular stocks among hedge funds at the end of the third quarter . Operator Welcome to the Evolent Earnings Conference Call for the Quarter and Year-Ended December 31, 2023. As a
Read at finance.yahoo.com
Evolent Health Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Evolent Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Evolent Health Fundamental Analysis
We analyze Evolent Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evolent Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evolent Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Evolent Health is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Evolent Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evolent Health stock to make a market-neutral strategy. Peer analysis of Evolent Health could also be used in its relative valuation, which is a method of valuing Evolent Health by comparing valuation metrics with similar companies.
Peers
Evolent Health Related Equities
AMWL | American Well | 5.05 | ||||
TDOC | Teladoc | 4.81 | ||||
TXG | 10X Genomics | 2.71 | ||||
SDGR | Schrodinger | 2.54 | ||||
PGNY | Progyny | 0.58 | ||||
GEHC | GE HealthCare | 0.27 | ||||
GDRX | Goodrx Holdings | 0.41 | ||||
CERT | Certara | 0.53 | ||||
DOCS | Doximity | 0.73 | ||||
HQY | HealthEquity | 0.91 |
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
CEOs Directory Screen CEOs from public companies around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies |